18 Members•4,119 Posts

Health

Tiziana reports encouraging Expanded Access data for Foralumab in MS patients

May 19, 2026

Steve Darling

Inside Biotech: Island Pharmaceuticals pushes deeper into US biodefence as Ebola fears spark interest

May 19, 2026

Lisa Uhlman

Tiziana Life Sciences price target boosted on foralumab update

May 19, 2026

Emily Jarvie

OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment

May 19, 2026

Steve Darling

BCAL expands early cancer detection access to 97% of Australian GPs

May 19, 2026

Jonathan Jackson

Cavendish sees IXICO forecasts as conservative after order book hits five-year high

May 19, 2026

Ian Lyall

OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board

May 19, 2026

Emily Jarvie

Tiziana Life Sciences reports encouraging one-year data for intranasal foralumab in progressive MS

May 19, 2026

Angela Harmantas

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout

May 19, 2026

Angela Harmantas

NanoViricides closes $2M direct offering

May 19, 2026

Emily Jarvie

BioHarvest Sciences and Tate & Lyle expand sweetener development program

May 19, 2026

Emily Jarvie

BioVie completes final patient visit in Parkinson's drug trial

May 19, 2026

Angela Harmantas

Coiled Therapeutics begins trading on US OTCQB market to broaden investor base

May 19, 2026

Ian Lyall

EMV Capital grows assets under management to £112.5m as venture platform scales

May 19, 2026

Ian Lyall

IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates

May 19, 2026

Stephen Gunnion

IXICO targets 15% revenue growth as order book swells and strategy takes shape

May 19, 2026

Ian Lyall

EMV Capital reports FY25 AUM of £112M as CEO targets £200M as the next milestone

May 19, 2026

Stephen Gunnion

Alcidion expands patient flow footprint with Telstra Health Kyra acquisition

May 18, 2026

Lisa Uhlman

Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says

May 18, 2026

Ian Lyall

Algorae completes AI prediction phase for expanded drug combination program

May 18, 2026

Jonathan Jackson

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy